Trending...
- Revolutionize Tracking with the iLocate Mini Tracker from Endoacustica Europe!
- Art Exhibition - Mandolene: Hard Edge for a New Generation
- Enhancing Residential Living with Air-Driven Home Elevators in Quebec
Basket trial of neoantigen synthetic long peptide vaccines for patients with advanced malignancy, run by the Jaime Leandro Foundation in association with Washington University of St. Louis
SAN FRANCISCO - CuisineWire -- WideTrial, Inc. will provide key regulatory support to a personalized cancer treatment program run by the Jaime Leandro Foundation for Therapeutic Cancer Vaccines (JLF) in association with Washington University School of Medicine in St. Louis.
In a basket trial for neoantigen synthetic long peptide vaccines, patients with advanced malignancies will be given a customized mix of neoantigen peptides based on their individual tumor mutation profiles. Cancer patients who do not meet the trial's eligibility criteria or who are geographically remote from the trial centers may still gain the personalized treatment through an Expanded Access Program (an "EAP").
WideTrial will conduct the planning and regulatory filings required for FDA-authorized Cost Recovery for both the research trial and the EAP.
"The recent draft Guidance on Charging for Investigational Treatment under an IND was a great step by FDA to clarify Cost Recovery rules, but it's still a complicated matter," said Jess Rabourn, CEO of WideTrial. "Our company was created to make this space easier to navigate, ensuring that non-traditional clinical trials, including Expanded Access Programs, are feasible for more clinics to offer to more patients as a care option."
More on Cuisine Wire
In the United States, all Expanded Access Programs and some research trials are eligible for Cost Recovery. This permits a sponsor to pass through some of its costs to interested parties. It is intended for cases in which the cost burden on the sponsor would otherwise severely restrict the feasibility or scope of the program.
"We reached out to WideTrial because of Jess's long-standing leadership in Expanded Access but also for his reputation for helping companies understand and utilize Cost Recovery in their clinical development," said William Hoos, President of JLF. "It's been a successful partnership so far."
WideTrial Inc. is a Silicon Valley based health-tech corporation. Its mission is to make investigational treatment options accessible to all patients with serious and life-threatening health conditions. To learn more, visit widetrial.com
The Jaime Leandro Foundation for Therapeutic Cancer Vaccines (JLF) is a 501(c)3 nonprofit organization that organizes the complex process necessary to give patients and doctors access to personalized neoantigen vaccines.
In a basket trial for neoantigen synthetic long peptide vaccines, patients with advanced malignancies will be given a customized mix of neoantigen peptides based on their individual tumor mutation profiles. Cancer patients who do not meet the trial's eligibility criteria or who are geographically remote from the trial centers may still gain the personalized treatment through an Expanded Access Program (an "EAP").
WideTrial will conduct the planning and regulatory filings required for FDA-authorized Cost Recovery for both the research trial and the EAP.
"The recent draft Guidance on Charging for Investigational Treatment under an IND was a great step by FDA to clarify Cost Recovery rules, but it's still a complicated matter," said Jess Rabourn, CEO of WideTrial. "Our company was created to make this space easier to navigate, ensuring that non-traditional clinical trials, including Expanded Access Programs, are feasible for more clinics to offer to more patients as a care option."
More on Cuisine Wire
- Bavarian Inn Lodge's Martha Zehnder Kaczynski Honored with Outstanding Volunteer Funder Award
- The CPSE Shenzhen 2023 was inaugurated on October
- Bill Edwards Foundation for the Arts and Ericka Dunlap Collaborate with Local Nonprofits to Celebrate Diversity at Mahaffey
- New York Young Republican Club Endorses Allen Mashburn For Lieutenant Governor Of North Carolina
- Diane Gray-Smith Joins STS Capital Partners
In the United States, all Expanded Access Programs and some research trials are eligible for Cost Recovery. This permits a sponsor to pass through some of its costs to interested parties. It is intended for cases in which the cost burden on the sponsor would otherwise severely restrict the feasibility or scope of the program.
"We reached out to WideTrial because of Jess's long-standing leadership in Expanded Access but also for his reputation for helping companies understand and utilize Cost Recovery in their clinical development," said William Hoos, President of JLF. "It's been a successful partnership so far."
WideTrial Inc. is a Silicon Valley based health-tech corporation. Its mission is to make investigational treatment options accessible to all patients with serious and life-threatening health conditions. To learn more, visit widetrial.com
The Jaime Leandro Foundation for Therapeutic Cancer Vaccines (JLF) is a 501(c)3 nonprofit organization that organizes the complex process necessary to give patients and doctors access to personalized neoantigen vaccines.
Source: WideTrial
0 Comments
Latest on Cuisine Wire
- Experience the Magic of the Holidays with Fun Corporate Magic's Virtual and In-Person Shows
- Zeus Investments Korea look at how AI is changing the investment landscape
- Art Exhibition - Mandolene: Hard Edge for a New Generation
- Small businesses collaborate to offer unique gift set this holiday season
- Brick's is bringing the Blues to the BBQ
- Clasico Chophouse and Taproom celebrating one-year anniversary
- Study Finds Lotus Vaping Technologies' Flavored E-Liquids Reduce Smokers' Cigarettes Per Day at Significantly Higher Rate Than Tobacco Flavor
- Vine Strategy review OpenAI: A Leader in the AI Market
- L2 Aviation and Klatt Works announce MOU for the revolutionary aircraft Smoke Assured Vision Enhanced Display (SAVED) Safety System
- Link.Store Launches the Ultimate Etsy Shop Manager Manual – A Comprehensive Guide for Thriving on Etsy
- CENTURY 21 Edge Enhances Focus on Central Florida through Sale of Pembroke Pines Office to CENTURY 21 Integra
- Robert D. Botticelli, Director of Business Development for Century Fasteners Corp., Honored by ADDAPT
- Tone Commander Phones Now Certified for Interoperability with Zoom for Government
- The Pulse of Perseverance App Takes Center Stage in an Unforgettable Evening of Innovation, Culinary Excellence, and Philanthropy
- Uncorking Wine Country Innovates Online Booking Wine Tasting Tours
- Debt Relief Programs: "Gearing Up for a Debt-Free Future: Innovative Tools and Technologies from Leading Companies" by 3d Chess Media
- Patriot Urgent Care Opens Much Needed Urgent Care Clinic in Fort Washington
- Spicin Foods Releases One-of-a-Kind Branded Merchandise
- Boujiemana Restaurant Announces Its Grand Opening At Their New Serra Mesa, San Diego Location
- Brice Capital's Pre-Thanksgiving Masterclass on Credit Card Debt Reduction Draws 7,500 Participants